Research and Development

Showing 15 posts of 9607 posts found.

Despite persistent need, J&J halts COVID-19 vaccine output

February 9, 2022 Research and Development

Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …

Novavax submits EUA to FDA for COVID-19 vaccine candidate

February 2, 2022 Research and Development

Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …

Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO

February 2, 2022 Research and Development

The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …

FDA approval of six-annual-dose HIV treatment

February 2, 2022 Research and Development

ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for

First European filing submission for multiple myeloma bispecific antibody

February 2, 2022 Research and Development

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …

FDA clearance of Investigational New Drug Application for novel peanut allergy vaccine

January 26, 2022 Research and Development

Allergy Therapeutics has announced the FDA clearance of the Investigational New Drug Application (IND) for its novel virus-like particle (VLP)-based …

Highest UK COVID-19 deaths since February as Pfizer begin trials for Omicron jab

January 26, 2022 Research and Development

Pfizer has begun clinical trials for its new COVID-19 vaccine tailored to the Omicron variant, and has shared that it …

Maxim Biomedical receives EUA for ClearDetect COVID-19 antigen home test

January 26, 2022 Research and Development

Maxim Biomedical have received an Emergency Use Authorisation (EUA) from the FDA for their new ClearDetect COVID-19 Antigen Home Test. …

New study highlights cell power as a functional biomarker for preventing tumour escape

January 26, 2022 Research and Development

LUMICKS announced that new research findings published in Translational Medicine detailed a novel design strategy for preventing tumour escape through …

Engitix and Dompé collaboration for fibrosis and cancer AI drug discovery

January 19, 2022 Research and Development

Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …
e-6olmfwuay74lr

MHRA license Jyseleca for treatment of ulcerative colitis

January 19, 2022 Research and Development

Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …

UK launch of generic lenalidomide for myeloma

January 19, 2022 Research and Development

Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …

SMC accepts first-line treatment for lung cancer

January 19, 2022 Research and Development

The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …

White House announces plans to double COVID-19 tests for schools

January 12, 2022 Research and Development

The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …

South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine

January 12, 2022 Research and Development

Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …
The Gateway to Local Adoption Series

Latest content